Distinct cell-specific control of autoimmunity and infection by FcγRIIb

Journal of Experimental Medicine

Volumn 205, Issue 4, 2008, Pages 883-895

  Brownlie, Rebecca J ^a   Lawlor, Kate E ^a   Niederer, Heather A ^a   Cutler, Antony J ^a,c   Xiang, Zou ^a   Clatworthy, Menna R ^a   Floto, R Andres ^a,d   Greaves, David R ^b   Lyons, Paul A ^a   Smith, Kenneth G C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c NHS BLOOD AND TRANSPLANT   (United Kingdom)

^d PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FC RECEPTOR IIB; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CONTROLLED STUDY; IMMUNE RESPONSE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSGENICS;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD86; ARTHRITIS, EXPERIMENTAL; AUTOIMMUNITY; B-LYMPHOCYTES; BACTERIAL INFECTIONS; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOGLOBULIN G; INFECTION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MACROPHAGES; MICE; MICE, TRANSGENIC; ORGAN SPECIFICITY; PHOSPHORYLATION; RECEPTORS, IGG; T-LYMPHOCYTES; TRANSGENES;

EID: 42249096407     PISSN: 00221007     EISSN: 00221007     Source Type: Journal    
DOI: 10.1084/jem.20072565     Document Type: Article

References (57)

1. Nimmerjahn, F., and J.V. Ravetch. 2006. Fcgamma receptors: old friends and new family members. Immunity. 24:19-28.
2. Ravetch, J.V., and S. Bolland. 2001. IgG Fc receptors. Annu. Rev. Immunol. 19:275-290.
3. Xiang, Z., A.J. Cutler, R.J. Brownlie, K. Fairfax, K.E. Lawlor, E. Severinson, E.U. Walker, R.A. Manz, D.M. Tarlinton, and K.G.C. Smith. 2007. FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat. Immunol. 8:419-429.
4. Takai, T., M. Ono, M. Hikida, H. Ohmori, and J.V. Ravetch. 1996. Augmented humoral and anaphylactic responses in Fc gamma RII-deficient mice. Nature. 379:346-349.
5. Takai, T. 2005. Fc receptors and their role in immune regulation and autoimmunity. J. Clin. Immunol. 25:1-18.
6. b mice susceptible to collagen-induced arthritis. J. Exp. Med. 189:187-194.
7. Clynes, R., J.S. Maizes, R. Guinamard, M. Ono, T. Takai, and J.V. Ravetch. 1999. Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189:179-185.
8. -/-- mice. J. Exp. Med. 195:1167-1174.
9. Pritchard, N.R., A.J. Cutler, S. Uribe, S.J. Chadban, B.J. Morley, and K.G.C. Smith. 2000. Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII. Curr. Biol. 10:227-230.
10. Xiu, Y., K. Nakamura, M. Abe, N. Li, X.S. Wen, Y. Jiang, D. Zhang, H. Tsurui, S. Matsuoka, Y. Hamano, et al. 2002. Transcriptional regulation of Fcgr2b gene by polymorphic promoter region and its contribution to humoral immune responses. J. Immunol. 169:4340-4346.
11. Rahman, Z.S., H. Niu, D. Perry, E. Wakeland, T. Manser, and L. Morel. 2007. Expression of the autoimmune Fcgr2b NZW allele fails to be upregulated in germinal center B cells and is associated with increased IgG production. Genes Immun. 8:604-612.
12. Jiang, Y., S. Hirose, R. Sanokawa-Akakura, M. Abe, X. Mi, N. Li, Y. Miura, J. Shirai, D. Zhang, Y. Hamano, and T. Shirai. 1999. Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus. Int. Immunol. 11:1685-1691.
13. Kyogoku, C., H.M. Dijstelbloem, N. Tsuchiya, Y. Hatta, H. Kato, A. Yamaguchi, T. Fukazawa, M.D. Jansen, H. Hashimoto, J.G. van de Winkel, C.G. Kallenberg, and K. Tokunaga. 2002. Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility. Arthritis Rheum. 46:1242-1254.
14. Su, K., H. Yang, X. Li, X. Li, A.W. Gibson, J.M. Cafardi, T. Zhou, J.C. Edberg, and R.P. Kimberly. 2007. Expression profile of FcgammaRIIb on leukocytes and its dysregulation in systemic lupus erythematosus. J. Immunol. 178:3272-3280.
15. Chu, Z.T., N. Tsuchiya, C. Kyogoku, J. Ohashi, Y.P. Qian, S.B. Xu, C.Z. Mao, J.Y. Chu, and K. Tokunaga. 2004. Association of Fcgamma receptor IIb polymorphism with susceptibility to systemic lupus erythematosus in Chinese: a common susceptibility gene in the Asian populations. Tissue Antigens. 63:21-27.
16. Floto, R.A., M.R. Clatworthy, K.R. Heilbronn, D.R. Rosner, P.A. MacAry, A. Rankin, P.J. Lehner, W.H. Ouwehand, J.M. Allen, N.A. Watkins, and K.G.C. Smith. 2005. Loss of function of a lupus-associated FcgammaRIIb polymorphism through exclusion from lipid rafts. Nat. Med. 11:1056-1058.
17. Kono, H., C. Kyogoku, T. Suzuki, N. Tsuchiya, H. Honda, K. Yamamoto, K. Tokunaga, and Z. Honda. 2005. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum. Mol. Genet. 14:2881-2892.
18. Clatworthy, M.R., and K.G.C. Smith. 2004. FcγRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis. J. Exp. Med. 199:717-723.
19. Clatworthy, M.R., L. Willcocks, B. Urban, J. Langhorne, T.N. Williams, N. Peshu, N.A. Watkins, R.A. Floto, and K.G.C. Smith. 2007. Systemic lupus erythematosus-associated defects in the inhibitory receptor FcgammaRIIb reduce susceptibility to malaria. Proc. Natl. Acad. Sci. USA. 104:7169-7174.
20. Liu, Y., E. Masuda, M.C. Blank, K.A. Kirou, X. Gao, M.S. Park, and L. Pricop. 2005. Cytokine-mediated regulation of activating and inhibitory Fc gamma receptors in human monocytes. J. Leukoc. Biol. 77:767-776.
21. Tridandapani, S., K. Siefker, J.L. Teillaud, J.E. Carter, M.D. Wewers, and C.L. Anderson. 2002. Regulated expression and inhibitory function of Fcgamma RIIb in human monocytic cells. J. Biol. Chem. 277:5082-5089.
22. Pricop, L., P. Redecha, J.L. Teillaud, J. Frey, W.H. Fridman, C. Sautes-Fridman, and J.E. Salmon. 2001. Differential modulation of stimulatory and inhibitory Fc gamma receptors on human monocytes by Th1 and Th2 cytokines. J. Immunol. 166:531-537.
23. Rudge, E.U., A.J. Cutler, N.R. Pritchard, and K.G.C. Smith. 2002. Interleukin 4 reduces expression of inhibitory receptors on B cells and abolishes CD22 and FcγRII-mediated B cell suppression. J. Exp. Med. 195:1079-1085.
24. O'Garra, A., K.P. Rigley, M. Holman, J.B. McLaughlin, and G.G. Klaus. 1987. B-cell-stimulatory factor 1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation. Proc. Natl. Acad. Sci. USA. 84:6254-6258.
25. Liu, Y., X. Gao, E. Masuda, P.B. Redecha, M.C. Blank, and L. Pricop. 2006. Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes. J. Immunol. 177:8440-8447.
26. Samuelsson, A., T.L. Towers, and J.V. Ravetch. 2001. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science. 291:484-486.
27. McGaha, T.L., B. Sorrentino, and J.V. Ravetch. 2005. Restoration of tolerance in lupus by targeted inhibitory receptor expression. Science. 307:590-593.
28. Nimmerjahn, F., and J.V. Ravetch. 2007. The antiinflammatory activity of IgG: the intravenous IgG paradox. J. Exp. Med. 204:11-15.
29. Higuchi, T., Y. Aiba, T. Nomura, J. Matsuda, K. Mochida, M. Suzuki, H. Kikutani, T. Honjo, K. Nishioka, and T. Tsubata. 2002. Cutting Edge: Ectopic expression of CD40 ligand on B cells induces lupus-like autoimmune disease. J. Immunol. 168:9-12.
30. Phillips, N.E., and D.C. Parker. 1983. Fc-dependent inhibition of mouse B cell activation by whole anti-mu antibodies. J. Immunol. 130:602-606.
31. Smith, K.G.C., A. Light, G.J.V. Nossal, and D.M. Tarlinton. 1997. The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J. 16:2996-3006.
32. Gough, P.J., S. Gordon, and D.R. Greaves. 2001. The use of human CD68 transcriptional regulatory sequences to direct high-level expression of class A scavenger receptor in macrophages in vitro and in vivo. Immunology. 103:351-361.
33. Choquet, D., M. Partiseti, S. Amigorena, C. Bonnerot, W.H. Fridman, and H. Korn. 1993. Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J. Cell Biol. 121:355-363.
34. Campbell, I.K., J.A. Hamilton, and I.P. Wicks. 2000. Collagen-induced arthritis in C57BL/6 (H-2b) mice: new insights into an important disease model of rheumatoid arthritis. Eur. J. Immunol. 30:1568-1575.
35. Svensson, L., J. Jirholt, R. Holmdahl, and L. Jansson. 1998. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111:521-526.
36. Holmdahl, R., L. Jansson, A. Larsson, and R. Jonsson. 1990. Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand. J. Immunol. 31:147-157.
37. Theofilopoulos, A.N., and F.J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269-390.
38. Shlomchik, M.J., M.P. Madaio, D. Ni, M. Trounstein, and D. Huszar. 1994. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180:1295-1306.
39. Perlmutter, R.M., D. Hansburg, D.E. Briles, R.A. Nicolotti, and J.M. Davie. 1978. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 121:566-572.
40. Jacob, J., R. Kassir, and G. Kelsoe. 1991. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med. 173:1165-1175.
41. Wu, X., N. Jiang, C. Deppong, J. Singh, G. Dolecki, D. Mao, L. Morel, and H.D. Molina. 2002. A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus. J. Immunol. 169:1587-1592.
42. Miwa, T., M.A. Maldonado, L. Zhou, X. Sun, H.Y. Luo, D. Cai, V.P. Werth, M.P. Madaio, R.A. Eisenberg, and W.C. Song. 2002. Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice. Am. J. Pathol. 161:1077-1086.
43. Bickerstaff, M.C., M. Botto, W.L. Hutchinson, J. Herbert, G.A. Tennent, A. Bybee, D.A. Mitchell, H.T. Cook, P.J. Butler, M.J. Walport, and M.B. Pepys. 1999. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5:694-697.
44. Botto, M. 1998. C1q knock-out mice for the study of complement deficiency in autoimmune disease. Exp. Clin. Immunogenet. 15:231-234.
45. Bygrave, A.E., K.L. Rose, J. Cortes-Hernandez, J. Warren, R.J. Rigby, H.T. Cook, M.J. Walport, T.J. Vyse, and M. Botto. 2004. Spontaneous autoimmunity in 129 and C57BL/6 mice-implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2:E243.
46. Terato, K., K.A. Hasty, R.A. Reife, M.A. Cremer, A.H. Kang, and J.M. Stuart. 1992. Induction of arthritis with monoclonal antibodies to collagen. J. Immunol. 148:2103-2108.
47. Nimmerjahn, F., and J.V. Ravetch. 2008. Fcgamma receptors as regulators of immune responses. Nat. Rev. Immunol. 8:34-47.
48. Nimmerjahn, F., and J.V. Ravetch. 2005. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science. 310:1510-1512.
49. Hamaguchi, Y., Y. Xiu, K. Komura, F. Nimmerjahn, and T.F. Tedder. 2006. Antibody isotype-specific engagement of Fcγ receptors regulates B lymphocyte depletion during CD20 immunotherapy. J. Exp. Med. 203:743-753.
50. Nimmerjahn, F., P. Bruhns, K. Horiuchi, and J.V. Ravetch. 2005. FcgammaRIV: a novel FcR with distinct IgG subclass specificity. Immunity. 23:41-51.
51. Watson, W.C., and A.S. Townes. 1985. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J. Exp. Med. 162:1878-1891.
52. Haas, C., B. Ryffel, and M. Le Hir. 1997. IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/lpr mice. J. Immunol. 158:5484-5491.
53. Wakeland, E., L. Morel, K. Achey, M. Yui, and J. Longmate. 1997. Speed congenics: a classic technique in the fast lane (relatively speaking). Immunol. Today. 18:472-477.
54. Melendez, A., R.A. Floto, D.J. Gillooly, M.M. Harnett, and J.M. Allen. 1998. FcgammaRI coupling to phospholipase D initiates sphingosine kinase-mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 273:9393-9402.
55. Sekine, H., C.M. Reilly, I.D. Molano, G. Garnier, A. Circolo, P. Ruiz, V.M. Holers, S.A. Boackle, and G.S. Gilkeson. 2001. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice. J. Immunol. 166:6444-6451.
56. Martinez, J.E., S. Romero-Steiner, T. Pilishvili, S. Barnard, J. Schinsky, D. Goldblatt, and G.M. Carlone. 1999. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin. Diagn. Lab. Immunol. 6:581-586.
57. Brown, J.S., A.D. Ogunniyi, M.C. Woodrow, D.W. Holden, and J.C. Paton. 2001. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection. Infect. Immun. 69:6702-6706.